<page><title>Duchenne and Becker muscular dystrophy</title><url>https://medlineplus.gov/genetics/condition/duchenne-and-becker-muscular-dystrophy</url><content>Duchenne and Becker muscular dystrophy
To use the sharing features on this page, please enable JavaScript.
Description
Muscular dystrophies are a group of genetic conditions characterized by progressive muscle weakness and wasting (atrophy). The Duchenne and Becker types of muscular dystrophy are two related conditions that primarily affect
skeletal muscles
, which are used for movement, and heart (cardiac) muscle. These forms of muscular dystrophy occur almost exclusively in males.
Duchenne and Becker muscular dystrophies have similar signs and symptoms and are caused by different mutations in the same gene. The two conditions differ in their severity, age of onset, and rate of progression. In boys with Duchenne muscular dystrophy, muscle weakness tends to appear in early childhood and worsen rapidly. Affected children may have delayed motor skills, such as sitting, standing, and walking. They are usually wheelchair-dependent by adolescence. The signs and symptoms of Becker muscular dystrophy are usually milder and more varied. In most cases, muscle weakness becomes apparent later in childhood or in adolescence and worsens at a much slower rate.
Both the Duchenne and Becker forms of muscular dystrophy are associated with a heart condition called cardiomyopathy. This form of heart disease weakens the cardiac muscle, preventing the heart from pumping blood efficiently. In both Duchenne and Becker muscular dystrophy, cardiomyopathy typically begins in adolescence. Later, the heart muscle becomes enlarged, and the heart problems develop into a condition known as dilated cardiomyopathy. Signs and symptoms of dilated cardiomyopathy can include an irregular heartbeat (arrhythmia), shortness of breath, extreme tiredness (fatigue), and
swelling of the legs and feet
. These heart problems worsen rapidly and become life-threatening in most cases. Males with Duchenne muscular dystrophy typically live into their twenties, while males with Becker muscular dystrophy can survive into their forties or beyond.
A related condition called
X-linked dilated cardiomyopathy
is a form of heart disease caused by mutations in the same gene as Duchenne and Becker muscular dystrophy, and it is sometimes classified as subclinical Becker muscular dystrophy. People with X-linked dilated cardiomyopathy typically do not have any skeletal muscle weakness or wasting, although they may have subtle changes in their skeletal muscle cells that are detectable through laboratory testing.
Frequency
Duchenne and Becker muscular dystrophies together affect 1 in 3,500 to 5,000 newborn males worldwide. Between 400 and 600 boys in the United States are born with these conditions each year.
Causes
Mutations in the
DMD
gene cause the Duchenne and Becker forms of muscular dystrophy. The
DMD
gene provides instructions for making a protein called
dystrophin
. This protein is located primarily in
skeletal
and cardiac muscle, where it helps stabilize and protect muscle fibers. Dystrophin may also play a role in chemical signaling within cells.
Mutations in the
DMD
gene alter the structure or function of dystrophin or prevent any functional dystrophin from being produced. Muscle cells without enough of this protein become damaged as muscles repeatedly contract and relax with use. The damaged fibers weaken and die over time, leading to the muscle weakness and heart problems characteristic of Duchenne and Becker muscular dystrophies.  Mutations that lead to an abnormal version of dystrophin that retains some function usually cause Becker muscular dystrophy, while mutations that prevent the production of any functional dystrophin tend to cause Duchenne muscular dystrophy.
Because Duchenne and Becker muscular dystrophies result from faulty or missing dystrophin, these conditions are classified as dystrophinopathies.
Learn more about the gene associated with Duchenne and Becker muscular dystrophy
DMD
Inheritance
This condition is inherited in an
X-linked recessive
pattern. The gene associated with this condition is located on the X chromosome, which is one of the two
sex chromosomes
. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
In many cases, an affected male inherits the mutation from his mother, who carries one altered copy of the
DMD
gene. The remainder of cases probably result from new mutations in the gene in affected males and are not inherited.
In X-linked recessive inheritance, a female with one mutated copy of the gene in each cell is called a carrier. She can pass on the altered gene but usually does not experience signs and symptoms of the disorder. Occasionally, however, females who carry a
DMD
gene mutation may have muscle weakness and cramping. These symptoms are typically milder than the severe muscle weakness and atrophy seen in affected males. Females who carry a
DMD
gene mutation also have an increased risk of developing heart abnormalities including cardiomyopathy.
Other Names for This Condition
DBMD
Duchenne/Becker muscular dystrophy
Muscular dystrophy, Duchenne and Becker types
Muscular dystrophy, pseudohypertrophic
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Becker muscular dystrophy
Genetic Testing Registry: Duchenne muscular dystrophy
Genetic and Rare Diseases Information Center
Becker muscular dystrophy
Duchenne muscular dystrophy
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
MUSCULAR DYSTROPHY, BECKER TYPE; BMD
Scientific Articles on PubMed
PubMed
References
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A,
Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C;
DMD Care Considerations Working Group. Diagnosis and management of Duchenne
muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial
management. Lancet Neurol. 2010 Jan;9(1):77-93. doi:
10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27.
Citation on PubMed
Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. 2000 Sep 5 [updated 2022
Jan 20]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp
KW, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA):
University of Washington, Seattle; 1993-2024. Available from
http://www.ncbi.nlm.nih.gov/books/NBK1119/
Citation on PubMed
Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current
hypotheses. Pediatr Neurol. 2007 Jan;36(1):1-7. doi:
10.1016/j.pediatrneurol.2006.09.016.
Citation on PubMed
Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic
review and meta-analysis on the epidemiology of Duchenne and Becker muscular
dystrophy. Neuromuscul Disord. 2014 Jun;24(6):482-91. doi:
10.1016/j.nmd.2014.03.008. Epub 2014 Mar 22.
Citation on PubMed
Verma S, Anziska Y, Cracco J. Review of Duchenne muscular dystrophy (DMD) for
the pediatricians in the community. Clin Pediatr (Phila). 2010 Nov;49(11):1011-7.
doi: 10.1177/0009922810378738. Epub 2010 Aug 19. No abstract available.
Citation on PubMed
Wein N, Alfano L, Flanigan KM. Genetics and emerging treatments for Duchenne
and Becker muscular dystrophy. Pediatr Clin North Am. 2015 Jun;62(3):723-42. doi:
10.1016/j.pcl.2015.03.008. Epub 2015 Apr 20.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>